Several groups have shown the role of increased CD4+ populations in long-term survivors in studies of 4T1 TNBC, B16F10 melanoma, and CT26 colon cancer mouse models, which is in agreement with our results (Figure 5l) [67,69,70]. This evidence concerns the gene CD4 and melanoma.